{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:56:16Z","timestamp":1784768176756,"version":"3.55.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["68,69"],"award-info":[{"award-number":["68,69"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.micpath.2022.105794","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:54:27Z","timestamp":1664326467000},"page":"105794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"PA","title":["Monkeypox virus: An emerging epidemic"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6338","authenticated-orcid":false,"given":"Alaa AA.","family":"Aljabali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad B.","family":"Nusair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hmedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza M.","family":"Tambuwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2022.105794_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/br.37.1.1-18.1973","article-title":"Monkeypox virus","volume":"37","author":"Cho","year":"1973","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.micpath.2022.105794_bib2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2022.105794_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","article-title":"Monkeypox virus and insights into its immunomodulatory proteins","volume":"225","author":"Weaver","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2022.105794_bib4","series-title":"Monkeypox: what We Know about the 2022 Outbreak So Far","author":"Looi","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2001.109302","article-title":"An overview of poxviruses","volume":"44","author":"Diven","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.micpath.2022.105794_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virusres.2009.05.006","article-title":"Poxvirus protein evolution: family wide assessment of possible horizontal gene transfer events","volume":"144","author":"Odom","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2022.105794_bib7","series-title":"Microbial Approaches for Insect Pest Management","first-page":"1","article-title":"Entomopathogenic viruses","author":"Harish","year":"2021"},{"key":"10.1016\/j.micpath.2022.105794_bib8","series-title":"Orthopoxviruses Pathogenic for Humans","author":"Shchelkunov","year":"2006"},{"key":"10.1016\/j.micpath.2022.105794_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jmv.25348","article-title":"A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria","volume":"91","author":"Kabuga","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2022.105794_bib10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/9781555816728.ch105","article-title":"Poxviruses","author":"Damon","year":"2011","journal-title":"Man. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2022.105794_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetmic.2009.08.026","article-title":"Zoonotic poxviruses","volume":"140","author":"Essbauer","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2022.105794_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-642-75605-4_3","article-title":"The role of telomeres in poxvirus DNA replication","author":"DeLange","year":"1990","journal-title":"Poxviruses"},{"key":"10.1016\/j.micpath.2022.105794_bib13","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1128\/JVI.75.21.10090-10105.2001","article-title":"Vaccinia virus telomeres: interaction with the viral I1, I6, and K4 proteins","volume":"75","author":"DeMasi","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2022.105794_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/mr.57.4.781-822.1993","article-title":"Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes","volume":"57","author":"Dougherty","year":"1993","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.micpath.2022.105794_bib15","series-title":"Encyclopedia of Toxicology","author":"Wexler","year":"2005"},{"key":"10.1016\/j.micpath.2022.105794_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virusres.2006.01.016","article-title":"Poxviruses: past, present and future","volume":"117","author":"Lefkowitz","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2022.105794_bib17","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micpath.2022.105794_bib18","first-page":"179","article-title":"Poxvirus infections","author":"Robinson","year":"2001","journal-title":"Infect. Dis. Wild. Mamm."},{"key":"10.1016\/j.micpath.2022.105794_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-4614-0980-9_17","article-title":"Assembly of large icosahedral double-stranded RNA viruses","author":"Poranen","year":"2012","journal-title":"Viral Mol. Machines."},{"key":"10.1016\/j.micpath.2022.105794_bib20","first-page":"156","volume":"vol. 46","author":"Magnus","year":"1959"},{"key":"10.1016\/j.micpath.2022.105794_bib21","first-page":"165","article-title":"Human monkeypox, 1970-79","volume":"58","author":"Breman","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micpath.2022.105794_bib22","first-page":"569","volume":"46","author":"Foster","year":"1972","journal-title":"Human monkeypox"},{"key":"10.1016\/j.micpath.2022.105794_bib23","series-title":"Monkeypox Virus. Animal-Origin Viral Zoonoses","first-page":"39","author":"Sklenovsk\u00e1","year":"2020"},{"key":"10.1016\/j.micpath.2022.105794_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214229","article-title":"The 2017 human monkeypox outbreak in Nigeria\u2014report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria","volume":"14","author":"Ogoina","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2022.105794_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.meegid.2013.10.014","article-title":"Poxviruses and the evolution of host range and virulence","volume":"21","author":"Haller","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2022.105794_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijid.2018.11.008","article-title":"Monkeypox - enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era","volume":"78","author":"Petersen","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1473-3099(18)30043-4","article-title":"Genomic characterisation of human monkeypox virus in Nigeria","volume":"18","author":"Faye","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib28","series-title":"Perception of Warri Metropolitan Residents on Online Newspaper Reportage of the Monkey Pox Virus Vaccination Hoax","author":"Okanume","year":"2018"},{"key":"10.1016\/j.micpath.2022.105794_bib29","series-title":"Epidemiological Update: Monkeypox Outbreak","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.micpath.2022.105794_bib31","first-page":"782","volume":"vol. 26","author":"Vaughan","year":"2020"},{"key":"10.1016\/j.micpath.2022.105794_bib32","first-page":"747","article-title":"Monkeypox virus: ecology and public health significance","volume":"66","author":"Khodakevich","year":"1988","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micpath.2022.105794_bib33","series-title":"Human Monkeypox: an Emerging Zoonotic Disease","author":"Parker","year":"2007"},{"key":"10.1016\/j.micpath.2022.105794_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib36","first-page":"2905","volume":"vol. 74","author":"Moss","year":"2001"},{"key":"10.1016\/j.micpath.2022.105794_bib37","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2022.105794_bib38","series-title":"Clinical Features and Management of Human Monkeypox: a Retrospective Observational Study in the UK","author":"Adler","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib39","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421","article-title":"Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy","volume":"27","author":"Antinori","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.micpath.2022.105794_bib40","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2022.105794_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2022.105794_bib42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fvl.11.27","article-title":"Development of the small-molecule antiviral ST-246 as a smallpox therapeutic","volume":"6","author":"Grosenbach","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.micpath.2022.105794_bib43","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the advisory committee on immunization Practices (ACIP) and the healthcare infection Control Practices advisory committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.micpath.2022.105794_bib44","series-title":"FDA Approves the First Drug with an Indication for Treatment of Smallpox","author":"Administration","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib45","series-title":"SIGA Announces Health Canada Regulatory Approval of Oral TPOXX","author":"Technologies","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib46","unstructured":"Agency E.M., Tecovirimat SIGA (2022). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecovirimat-siga."},{"key":"10.1016\/j.micpath.2022.105794_bib47","series-title":"SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX\u00ae (Tecovirimat)","author":"Technologies","year":"2022"},{"issue":"8","key":"10.1016\/j.micpath.2022.105794_bib48","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2022.105794_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003495-199652020-00006","volume":"52","author":"Lea","year":"1996","journal-title":"Cidofovir. Drugs."},{"key":"10.1016\/j.micpath.2022.105794_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00003495-199958020-00015","article-title":"Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS","volume":"58","author":"Plosker","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.micpath.2022.105794_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2022.105794_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2022.105794_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(02)00198-5","article-title":"In vitro activity of potential anti-poxvirus agents","volume":"57","author":"Kern","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2022.105794_bib55","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir activity against poxvirus infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2022.105794_bib56","first-page":"A73","article-title":"Cidofovir (HPMPC) treatment of monkeypox","volume":"37","author":"Huggins","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2022.105794_bib57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection","volume":"439","author":"Stittelaar","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2022.105794_bib58","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/JVI.00984-08","article-title":"Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox","volume":"83","author":"Wei","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2022.105794_bib59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(02)02091-6","article-title":"Cidofovir in the therapy and short-term prophylaxis of poxvirus infections","volume":"23","author":"De Clercq","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2022.105794_bib60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2022.105794_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0091270002239705","article-title":"Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis","volume":"43","author":"Wolf","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.micpath.2022.105794_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.antiviral.2006.10.009","article-title":"Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice","volume":"73","author":"Hostetler","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2022.105794_bib63","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","article-title":"Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies","volume":"38","author":"Tippin","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.micpath.2022.105794_bib64","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","article-title":"Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir","volume":"48","author":"Quenelle","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2022.105794_bib65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2016.12.015","article-title":"Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox","volume":"139","author":"Crump","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2022.105794_bib66","first-page":"397","article-title":"Smallpox: emergence, global spread, and eradication","volume":"15","author":"Fenner","year":"1993","journal-title":"Hist. Philos. Life Sci."},{"key":"10.1016\/j.micpath.2022.105794_bib67","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","article-title":"Human monkeypox and smallpox viruses: genomic comparison","volume":"509","author":"Shchelkunov","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.micpath.2022.105794_bib68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3855\/jidc.1204","article-title":"The eradication of smallpox, a success story for modern medicine and public health: what lessons for the future?","volume":"4","author":"Tognotti","year":"2010","journal-title":"J. Infect. Devel Countries"},{"key":"10.1016\/j.micpath.2022.105794_bib69","first-page":"425","article-title":"Smallpox and its post-eradication surveillance","volume":"65","author":"Jezek","year":"1987","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micpath.2022.105794_bib70","series-title":"World Population Review","year":"2020"},{"key":"10.1016\/j.micpath.2022.105794_bib71","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0150","article-title":"Vacated niches, competitive release and the community ecology of pathogen eradication","volume":"368","author":"Lloyd-Smith","year":"2013","journal-title":"Phil. Trans. Biol. Sci."},{"key":"10.1016\/j.micpath.2022.105794_bib72","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization Practices\u2014United States","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.micpath.2022.105794_bib73","series-title":"Smallpox. Vaccines","first-page":"333","author":"Bonville","year":"2021"},{"key":"10.1016\/j.micpath.2022.105794_bib74","series-title":"Rotavirus Infection Etiology","first-page":"313","author":"Bonville","year":"2020"},{"key":"10.1016\/j.micpath.2022.105794_bib75","series-title":"Monkeypox","author":"WHO Organization","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib77","series-title":"FDA APPROVAL OF JYNNEOS\u2122 (SMALLPOX AND MONKEYPOX VACCINE, LIVE, NON-REPLICATING) FOR PREVENTION OF SMALLPOX AND MONKEYPOX DISEASE IN ADULTS","author":"Nordic","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib78","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3201\/eid2505.190076","article-title":"Diagnosis of imported monkeypox, Israel","volume":"25","author":"Erez","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib79","series-title":"Monkeypox: Information for Primary Care","author":"England","year":"2022"},{"key":"10.1016\/j.micpath.2022.105794_bib80","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S1473-3099(19)30537-7","article-title":"A case of imported Monkeypox in Singapore","volume":"19","author":"Ng","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105794_bib81","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2022.105794_bib82","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.micpath.2022.105794_bib83","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1546298","article-title":"Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA","volume":"255","author":"Jirikowski","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.micpath.2022.105794_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2022.105794_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2022.105794_bib86","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2022.105794_bib87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/08982104.2018.1531424","article-title":"Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown","volume":"29","author":"Obeid","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.micpath.2022.105794_bib88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.micpath.2022.105794_bib89","series-title":"Melanoma","first-page":"621","article-title":"Sirna delivery to melanoma cells with cationic niosomes","author":"Obeid","year":"2021"},{"key":"10.1016\/j.micpath.2022.105794_bib90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4155\/tde-2018-0051","article-title":"Exosomes: fighting cancer with cancer","volume":"10","author":"Alyamani","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.micpath.2022.105794_bib91","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2022.03.032","article-title":"mRNA vaccines for COVID-19 and diverse diseases","volume":"345","author":"Hussain","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2022.105794_bib93","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2022.105794_bib94","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.2147\/IJN.S325901","article-title":"Potentiality of melittin-loaded niosomal vesicles against vancomycin-intermediate Staphylococcus aureus and Staphylococcal skin infection","volume":"16","author":"Sangboonruang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2022.105794_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110559","article-title":"Targeting SARS-CoV2 spike protein receptor binding domain by therapeutic antibodies","volume":"130","author":"Hussain","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2022.105794_bib97","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2022.105794_bib98","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2020.16866","article-title":"COVID-19 and mRNA vaccines\u2014first large test for a new approach","volume":"324","author":"Abbasi","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2022.105794_bib99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.micpath.2022.105794_bib100","series-title":"Covid-19 mRNA Vaccines\u2014Six of One, Half a Dozen of the Other","first-page":"183","author":"Rubin","year":"2022"},{"issue":"8","key":"10.1016\/j.micpath.2022.105794_bib102","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1016\/S2666-5247(22)00153-7","article-title":"Global human monkeypox outbreak: atypical presentation demanding urgent public health action","volume":"3","author":"Otu","year":"2022","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.micpath.2022.105794_bib103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejpb.2021.12.014","article-title":"Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor","volume":"171","author":"Gebril","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.micpath.2022.105794_bib104","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/978-1-0716-1205-7_41","article-title":"Use of nanoparticles in delivery of nucleic acids for melanoma treatment","volume":"2265","author":"Obeid","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.micpath.2022.105794_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4155\/tde-2021-0075","article-title":"SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments","volume":"13","author":"Adesokan","year":"2022","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.micpath.2022.105794_bib106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2022.105794_bib107","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.vaccine.2020.08.050","article-title":"The Brighton Collaboration standardized template for collection of key information for risk\/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform","volume":"39","author":"Volkmann","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2022.105794_bib108","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2022.105794_bib109","unstructured":"Adminstration UfaD., JYNNEOS (2022). https:\/\/www.fda.gov\/media\/160858\/download."},{"key":"10.1016\/j.micpath.2022.105794_bib110","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4161\/hv.24319","article-title":"Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(\u00ae) compared with Dryvax(\u00ae)","volume":"9","author":"Tack","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2022.105794_bib111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2022.105794_bib112","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.micpath.2022.105794_bib113","series-title":"Monkeypox: what Do We Know about the Outbreaks in Europe and North America?","author":"Mahase","year":"2022"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022004077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022004077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:41:50Z","timestamp":1760110910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022004077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":110,"alternative-id":["S0882401022004077"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105794","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monkeypox virus: An emerging epidemic","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105794"}}